Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and Sequestered Naltrexone, in Patients with Chronic, Moderate to Severe Pain

Lynn R. Webster(Adherent Technologies (United States)), Joseph Stauffer, Doreen Sekora, Randall P. Brewer(Willis-Knighton Cancer Center), Chao Wang(Monash University), David Morris, Franklin K. Johnson(Université Paris-Saclay)
Journal of Pain and Symptom Management
November 1, 2010
10.1016/j.jpainsymman.2010.05.004
Cited by 40

Related Papers

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
|Pain|2003|3.5k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331